• Andrew Mok from Barclays sets a new price target for Molina Healthcare (NYSE: MOH) at $133, indicating a potential increase of 4.29%.
• Grabar Law Office investigates potential breaches of fiduciary duties by Molina's officers and directors related to undisclosed adverse facts about its "medical cost trend assumptions."
• Molina Healthcare's stock shows significant fluctuations, with a current price of $127.53, reflecting a decrease of 3.18% or $4.19.

Molina Healthcare (NYSE: MOH) is a prominent player in the healthcare sector, providing managed health care services under the Medicaid and Medicare programs. The company operates across several states in the U.S., offering health plans to low-income families and individuals. Molina competes with other healthcare giants like UnitedHealth Group and Centene Corporation.

On February 10, 2026, Andrew Mok from Barclays set a new price target for Molina Healthcare at $133. At that time, the stock was trading at $127.53, indicating a potential increase of 4.29%. This target suggests optimism about Molina's future performance despite current challenges.

Grabar Law Office is investigating potential breaches of fiduciary duties by Molina's officers and directors. This investigation is tied to a securities fraud class action complaint, which alleges that the company failed to disclose important adverse facts about its "medical cost trend assumptions." This legal scrutiny could impact investor confidence.

Currently, MOH is priced at $127.53, showing a decrease of 3.18% or $4.19. The stock has experienced significant fluctuations, with a daily range between $123.73 and $135.94. Over the past year, it reached a high of $359.97 and a low of $123.73, reflecting volatility in its market performance.

Molina Healthcare has a market capitalization of approximately $6.56 billion, indicating its size and market presence. The trading volume for the day is 4,660,173 shares on the NYSE, suggesting active investor interest. Despite legal challenges, the company's market activity remains robust.